RETA - レアタ・ファ―マシュ―ティカルズ (Reata Pharmaceuticals Inc.)

RETAのニュース

   Earnings Scheduled For August 10, 2020  2020/08/10 08:10:24 Benzinga
Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand. • Akebia Therapeutics Inc. (NASDAQ: AKBA ) is expected to report quarterly loss at $0.50 per share on revenue of $74.18 million. • Apyx Medical Inc. (NASDAQ: APYX ) is estimated to report quarterly loss at $0.21 per share on revenue of $1.96 million. • Avadel Pharmaceuticals Inc. (NASDAQ: AVDL ) is estimated to report quarterly loss at $0.10 per share on revenue of $7.37 million. • Axsome Therapeutics Inc. (NASDAQ: AXSM ) is estimated to report earnings for its second quarter. • Liberty Braves Group Inc. (NASDAQ: BATRK ) is estimated to report earnings for its second quarter. • Biohaven Pharmaceutical Inc. (NYSE: BHVN ) is expected to report earnings for its second quarter. • Black Knight Inc. (NYSE: BKI ) is expected to report quarterly earnings at $0.47 per share on revenue of $290.66 million. • Bluerock Residential Growth REIT, Inc.
   The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings  2020/08/09 13:05:25 Benzinga
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus treatment/vaccine news flow supported the move to the upside. Novavax, Inc.'s (NASDAQ: NVAX ) stretched valuation got further stretched as the shares added about 20% for the week in the wake of its interim Phase 1 readout for its coronavirus vaccine candidate . Bristol-Myers Squibb Co (NYSE: BMY ) reported a beat-and-raise quarter, with the shares receiving further support from a win in the patent lawsuit over its blood thinner Eliquis. The week also saw a medical technology and two biotechs debuting on the Wall Street. Here are the key catalysts for the unfolding week. Conferences BTIG Virtual Biotechnology Conference: Aug. 10-11 Wedbush PacGrow Healthcare Virtual Conference: Aug. 11-12 PDUFA Dates The FDA is said to rule on the NDA filed by Bausch Health Companies Inc (NYSE: BHC ) for EM-100, an investigational therapy for allergic conjunctivitis.
   Regal Entertainment parent to open all movie theaters by July  2020/06/16 18:45:37 New York Post
Regal Entertainment parent Cineworld Group said Tuesday it will reopen select theaters at the end of the month in some of its markets. All 787 of the company’s theaters are expected to be up and running by July 10. The move comes after cinemas worldwide have temporarily shut their doors due to the coronavirus pandemic,…
   Reata Pharma, PennyMac rise; Oxford, Spirit AeroSystems fall  2020/06/11 20:40:32 ABC News
Stocks that moved heavily or traded substantially on Thursday: Reata Pharma, PennyMac rise; Oxford, Spirit AeroSystems fall
   Plano-based Reata’s stock soars 26% after scoring $350 million investment from Blackstone  2020/06/11 16:58:19 The Dallas Morning News
Plano-based Reata Pharmaceuticals Inc. is getting a $350 million infusion from a Wall Street titan to aid in bringing its chronic kidney disease drug to…
   Regal Entertainment parent to open all movie theaters by July  2020/06/16 18:45:37 New York Post
Regal Entertainment parent Cineworld Group said Tuesday it will reopen select theaters at the end of the month in some of its markets. All 787 of the company’s theaters are expected to be up and running by July 10. The move comes after cinemas worldwide have temporarily shut their doors due to the coronavirus pandemic,…
   Reata Pharma, PennyMac rise; Oxford, Spirit AeroSystems fall  2020/06/11 20:40:32 ABC News
Stocks that moved heavily or traded substantially on Thursday: Reata Pharma, PennyMac rise; Oxford, Spirit AeroSystems fall
   Plano-based Reata’s stock soars 26% after scoring $350 million investment from Blackstone  2020/06/11 16:58:19 The Dallas Morning News
Plano-based Reata Pharmaceuticals Inc. is getting a $350 million infusion from a Wall Street titan to aid in bringing its chronic kidney disease drug to…
   Reata Pharmaceuticals : to Get $350 Million Investment From Blackstone Life Sciences | MarketScreener  2020/06/11 12:04:04 MarketScreener
By Colin Kellaher Reata Pharmaceuticals Inc. on Thursday said it will receive $350 million under a royalty and equity investment deal with private-equity firm Blackstone Group Inc. The… | June 11, 2020
   Cineworld Reaffirms Plans to Close $2.1 Billion Deal for Cineplex Theater Chain  2020/05/07 21:20:39 The Hollywood Reporter
Canadian exhibition giant Cineplex on Thursday said its U.K.-based suitor, Cineworld Group, which also owns Regal Entertainment Group, remains committed to completing a $2.1 billion acquisition to create one of the world's largest cinema companies with over 11,200 screens globally.
   Cineworld Reaffirms Plans to Close $2.1 Billion Deal for Cineplex Theater Chain  2020/05/07 21:20:39 The Hollywood Reporter
Canadian exhibition giant Cineplex on Thursday said its U.K.-based suitor, Cineworld Group, which also owns Regal Entertainment Group, remains committed to completing a $2.1 billion acquisition to create one of the world's largest cinema companies with over 11,200 screens globally.
   Reata Pharmaceuticals, Inc. (RETA) Down 37.8% Since Last Earnings Report: Can It Rebound?  2020/03/20 15:30:47 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …
   The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data  2020/02/05 12:43:12 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ALEC ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Therapeutics Inc (NASDAQ: APLT ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT )(IPOed Jan. 31) Black Diamond Therapeutics Inc (NASDAQ: BDTX )(IPOed Jan. 30) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Insmed Incorporated (NASDAQ: INSM )(reacted to positive analyst actions following a positive data readout reported Monday) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc.
   The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares  2020/02/04 12:51:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) ( announced a deal to buy cell and gene therapy CDMO MasTherCell and forecast-beating second quarter results) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Molecular Templates Inc (NASDAQ: MTEM ) Orgenesis Inc (NASDAQ: ORGS ) (announced sale of subsidiary MasTherCell to Catalent) Profound Medical Corp (NASDAQ: PROF ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) Theravance Biopharma Inc (NASDAQ: TBPH ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 3.) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Avanos Medical Inc (NYSE: AVNS ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) (moved along with China pharmaceutical stocks due to coronavirus) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc. (NASDAQ: GALT ) I-Mab (NASDAQ: IMAB ) (went public in mid-January) Intec Pharma Ltd (NASDAQ: NTEC ) TapImmune Inc. (NASDAQ: MRKR ) Omeros Corporation (NASDAQ: OMER ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) X4 …

calendar